Revisiting the metabolic syndrome
- PMID: 17137436
- DOI: 10.5694/j.1326-5377.2006.tb00644.x
Revisiting the metabolic syndrome
Abstract
Metabolic syndrome (MS) refers to the clustering of cardiometabolic risk factors - including abdominal obesity, hyperglycaemia, dyslipidaemia and elevated blood pressure - that are thought to be linked to insulin resistance. MS is associated with increased risk of cardiovascular disease and type 2 diabetes. MS is common, affecting a quarter to a third of adults, and its prevalence is rising, in parallel with increasing obesity and population ageing. Operational definitions of MS have been proposed by the World Health Organization and the National Cholesterol Education Program. Recently, the International Diabetes Federation proposed a global definition that emphasised the importance of central adiposity. In cardiovascular risk assessment, MS encapsulates the contribution of non-traditional risk factors and provides a clinically useful framework for early identification of people at increased long-term risk. It should be used in conjunction with standard algorithms based on conventional risk factors, which better predict short-term risk. Management of MS should emphasise lifestyle interventions (eg, physical activity, healthy diet and weight reduction) to reduce long-term risk of cardiovascular disease and diabetes. Those at increased short-term risk should also have individual risk factors treated according to established guidelines.
Comment in
-
Research misconduct: can Australia learn from the UK's stuttering system?Med J Aust. 2007 Jun 18;186(12):662-3. doi: 10.5694/j.1326-5377.2007.tb01097.x. Med J Aust. 2007. PMID: 17576192 No abstract available.
-
Revisiting the metabolic syndrome.Med J Aust. 2007 Jul 2;187(1):61; author reply 61. doi: 10.5694/j.1326-5377.2007.tb01131.x. Med J Aust. 2007. PMID: 17605719 No abstract available.
Similar articles
-
Epidemiology of the insulin resistance syndrome.Curr Diab Rep. 2003 Feb;3(1):73-9. doi: 10.1007/s11892-003-0057-2. Curr Diab Rep. 2003. PMID: 12643149 Review.
-
Does the prevalence of the metabolic syndrome improve by applying the International Diabetes Federation criteria?Public Health Nutr. 2007 Oct;10(10A):1173-80. doi: 10.1017/S1368980007000675. Public Health Nutr. 2007. PMID: 17903327
-
[A comparison of the application of two working definitions of metabolic syndrome in Chinese population].Zhonghua Yi Xue Za Zhi. 2004 Apr 2;84(7):534-8. Zhonghua Yi Xue Za Zhi. 2004. PMID: 15144584 Chinese.
-
Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature.Pharmacol Res. 2017 Jun;120:34-42. doi: 10.1016/j.phrs.2017.03.008. Epub 2017 Mar 12. Pharmacol Res. 2017. PMID: 28300617 Review.
-
"The metabolic syndrome... is dead": these reports are an exaggeration.Cardiovasc Diabetol. 2011 Jan 27;10:11. doi: 10.1186/1475-2840-10-11. Cardiovasc Diabetol. 2011. PMID: 21269524 Free PMC article.
Cited by
-
Ethnic disparity in metabolic syndrome and related obesity and health behavior: a community study in Taiwan.Diabetol Metab Syndr. 2021 Nov 17;13(1):134. doi: 10.1186/s13098-021-00751-3. Diabetol Metab Syndr. 2021. PMID: 34789325 Free PMC article.
-
Metabolic syndrome and its components associated with endothelial dysfunction in chronic kidney disease patients.Vasc Health Risk Manag. 2012;8:15-21. doi: 10.2147/VHRM.S27444. Epub 2012 Jan 6. Vasc Health Risk Manag. 2012. PMID: 22272071 Free PMC article.
-
Effect of glycemic control and dyslipidemia on plasma vascular endothelial growth factor and pigment epithelium-derived factor in diabetic retinopathy patients in Northern Nigeria.Int J Health Sci (Qassim). 2020 Nov-Dec;14(6):4-12. Int J Health Sci (Qassim). 2020. PMID: 33192226 Free PMC article.
-
Clustering of cardiac risk factors associated with the metabolic syndrome and associations with psychosocial distress in a young Asian Indian population.J Behav Med. 2014 Aug;37(4):725-35. doi: 10.1007/s10865-013-9521-x. Epub 2013 Jun 18. J Behav Med. 2014. PMID: 23775637
-
New Zealand cardiovascular guidelines: best practice evidence-based guideline: the assessment and management of cardiovascular risk December 2003.Clin Biochem Rev. 2007 Feb;28(1):19-29. Clin Biochem Rev. 2007. PMID: 17603638 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical